WEC
Winslow Evans & Crocker’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $397K | Buy |
1,622
+69
| +4% | +$16.9K | 0.08% | 224 |
|
|
2020
Q3 | $441K | Hold |
1,553
| – | – | 0.11% | 179 |
|
|
2020
Q2 | $416K | Sell |
1,553
-1
| -0.1% | -$268 | 0.11% | 176 |
|
|
2020
Q1 | $492K | Sell |
1,554
-26
| -2% | -$8.23K | 0.16% | 131 |
|
|
2019
Q4 | $470K | Sell |
1,580
-10
| -0.6% | -$2.98K | 0.12% | 179 |
|
|
2019
Q3 | $372K | Hold |
1,590
| – | – | 0.1% | 202 |
|
|
2019
Q2 | $372K | Sell |
1,590
-4
| -0.3% | -$936 | 0.1% | 206 |
|
|
2019
Q1 | $378K | Buy |
1,594
+14
| +0.9% | +$3.32K | 0.11% | 198 |
|
|
2018
Q4 | $476K | Hold |
1,580
| – | – | 0.16% | 142 |
|
|
2018
Q3 | $560K | Hold |
1,580
| – | – | 0.17% | 137 |
|
|
2018
Q2 | $460K | Hold |
1,580
| – | – | 0.14% | 151 |
|
|
2018
Q1 | $433K | Hold |
1,580
| – | – | 0.14% | 145 |
|
|
2017
Q4 | $503K | Sell |
1,580
-12
| -0.8% | -$3.82K | 0.16% | 136 |
|
|
2017
Q3 | $498K | Sell |
1,592
-30
| -2% | -$9.39K | 0.17% | 135 |
|
|
2017
Q2 | $440K | Hold |
1,622
| – | – | 0.12% | 189 |
|
|
2017
Q1 | $443K | Hold |
1,622
| – | – | 0.14% | 157 |
|
|
2016
Q4 | $460K | Hold |
1,622
| – | – | 0.14% | 154 |
|
|
2016
Q3 | $508K | Hold |
1,622
| – | – | 0.15% | 148 |
|
|
2016
Q2 | $392K | Sell |
1,622
-20
| -1% | -$4.84K | 0.12% | 176 |
|
|
2016
Q1 | $427K | Hold |
1,642
| – | – | 0.13% | 158 |
|
|
2015
Q4 | $503K | Sell |
1,642
-176
| -10% | -$53.9K | 0.14% | 152 |
|
|
2015
Q3 | $530K | Buy |
1,818
+176
| +11% | +$51.3K | 0.17% | 134 |
|
|
2015
Q2 | $663K | Hold |
1,642
| – | – | 0.19% | 130 |
|
|
2015
Q1 | $693K | Sell |
1,642
-250
| -13% | -$106K | 0.2% | 116 |
|
|
2014
Q4 | $642K | Buy |
1,892
+44
| +2% | +$14.9K | 0.18% | 124 |
|
|
2014
Q3 | $611K | Sell |
1,848
-17
| -0.9% | -$5.62K | 0.18% | 133 |
|
|
2014
Q2 | $588K | Sell |
1,865
-606
| -25% | -$191K | 0.19% | 132 |
|
|
2014
Q1 | $756K | Hold |
2,471
| – | – | 0.26% | 93 |
|
|
2013
Q4 | $691K | Buy |
+2,471
| New | +$691K | 0.24% | 102 |
|